Literature DB >> 18261179

Acute insulin response to arginine in deceased donors predicts the outcome of human islet isolation.

T Hubert1, G Strecker, V Gmyr, L Arnalsteen, D Garrigue, R Ezzouaoui, R Caiazzo, G Dezfoulian, B Averland, B Vandewalle, M C Vantyghem, J Kerr-Conte, F Pattou.   

Abstract

Despite a stringent donor selection, human islet isolation remains frustratingly unpredictable. In this study, we measured acute insulin response to arginine (AIRarg), an in vivo surrogate measure of islet mass, in 29 human deceased donors before organ donation, and correlated values with the outcome of islet isolation. Thirteen isolations (45%) met the threshold for clinical islet transplantation. Among all measured donor characteristics, the only discriminating variable between successful or unsuccessful isolations was donor AIRarg (p < 0.01). Using a threshold of 55 microIU/mL (ROC curve AUC: 72%), isolation was successful in 12/19 donors with high AIRarg and in 1/10 donors with low AIRarg (p < 0.001). The negative and positive predictive values were 90 and 63%, respectively. If used to select donors in the entire cohort, AIRarg would have increased our success rate by 40% and avoided 56% of unsuccessful isolations while missing only 8% of successful preparations. Our results suggest that donor AIRarg is markedly superior to body mass index (BMI) and other criteria currently used to predict isolation outcome. If routinely performed in deceased donors, this simple test could significantly reduce the failure rate of human islet isolation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18261179     DOI: 10.1111/j.1600-6143.2007.02131.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  9 in total

1.  Predicting the outcome of islet isolation in large mammals.

Authors:  T Hubert; V Gmyr; M C Vantyghem; J Kerr-Conte; F Pattou
Journal:  Diabetologia       Date:  2008-11-21       Impact factor: 10.122

Review 2.  Re-engineering islet cell transplantation.

Authors:  Nicoletta Fotino; Carmen Fotino; Antonello Pileggi
Journal:  Pharmacol Res       Date:  2015-03-23       Impact factor: 7.658

3.  Continuous glucose monitoring analysis as predictor of islet yield and insulin requirements in autologous islet transplantation after complete pancreatectomy.

Authors:  Manuel Beltrán del Río; George Ivanov Georgiev; Renee Cercone; Mukesh Tiwari; Horacio L R Rilo
Journal:  J Diabetes Sci Technol       Date:  2014-09-04

Review 4.  Pancreatic Islet Transplantation in Humans: Recent Progress and Future Directions.

Authors:  Michael R Rickels; R Paul Robertson
Journal:  Endocr Rev       Date:  2019-04-01       Impact factor: 19.871

5.  Multicenter analysis of novel and established variables associated with successful human islet isolation outcomes.

Authors:  J S Kaddis; J S Danobeitia; J C Niland; T Stiller; L A Fernandez
Journal:  Am J Transplant       Date:  2010-01-05       Impact factor: 8.086

6.  Metabolic assessment prior to total pancreatectomy and islet autotransplant: utility, limitations and potential.

Authors:  R Lundberg; G J Beilman; T B Dunn; T L Pruett; S C Chinnakotla; D M Radosevich; R P Robertson; P Ptacek; A N Balamurugan; J J Wilhelm; B J Hering; D E R Sutherland; A Moran; M D Bellin
Journal:  Am J Transplant       Date:  2013-08-07       Impact factor: 8.086

7.  Comment on: Saisho et al. β-cell mass and turnover in humans: effects of obesity and aging. Diabetes Care 2013;36:111-117.

Authors:  Sofia A Gargani; Francois Pattou; Julie Kerr-Conte
Journal:  Diabetes Care       Date:  2013-07       Impact factor: 19.112

8.  Primary graft function, metabolic control, and graft survival after islet transplantation.

Authors:  Marie-Christine Vantyghem; Julie Kerr-Conte; Laurent Arnalsteen; Geraldine Sergent; Frederique Defrance; Valery Gmyr; Nicole Declerck; Violeta Raverdy; Brigitte Vandewalle; Pascal Pigny; Christian Noel; Francois Pattou
Journal:  Diabetes Care       Date:  2009-08       Impact factor: 19.112

9.  Stimulation of insulin secretion by large-dose oral arginine administration in healthy adults.

Authors:  Zhu-Qi Tang; Tao Wu; Shi-Wei Cui; Xiao-Hui Zhu; Tong Yin; Cui-Fang Wang; Jing-Yi Zhu; Ai-Juan Wu
Journal:  Exp Ther Med       Date:  2013-05-16       Impact factor: 2.447

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.